It’s probably safe to say there’s no stock more controversial than Valeant Pharmaceuticals. Jim…
Tag:
Comeback
-
-
Looking for something to snack on? Jim Cramer sat down with Irene Rosenfeld, the…
-
Mark Tepper of Strategic Wealth Partners and Todd Gordon of TradingAnalysis.com discuss Dow components…
-
Opko’s stock has been anything but healthy since its peak in June. Did its…
-
CNBC’s Leslie Picker looks at what’s happened to crypto hedge funds. And Dan Morehead,…
Older Posts